Rafi Mazor

725 total citations
23 papers, 582 citations indexed

About

Rafi Mazor is a scholar working on Epidemiology, Immunology and Physiology. According to data from OpenAlex, Rafi Mazor has authored 23 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Immunology and 6 papers in Physiology. Recurrent topics in Rafi Mazor's work include Adipokines, Inflammation, and Metabolic Diseases (5 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (4 papers) and Sodium Intake and Health (3 papers). Rafi Mazor is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (5 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (4 papers) and Sodium Intake and Health (3 papers). Rafi Mazor collaborates with scholars based in United States, Israel and Australia. Rafi Mazor's co-authors include Batya Kristal, Shifra Sela, Meital Cohen-Mazor, Geert W. Schmid‐Schönbein, Tom Alsaigh, Galina Shapiro, Revital Shurtz-Swirski, Judith Chezar, Ronit Geron and Kamal Hassan and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Hypertension.

In The Last Decade

Rafi Mazor

21 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafi Mazor United States 10 136 136 122 112 80 23 582
Aysel Kıyıcı Türkiye 16 73 0.5× 47 0.3× 78 0.6× 82 0.7× 82 1.0× 57 743
Adam Khader United States 11 86 0.6× 91 0.7× 170 1.4× 94 0.8× 57 0.7× 30 479
Judith Chezar Israel 12 68 0.5× 183 1.3× 120 1.0× 97 0.9× 120 1.5× 22 611
Gabriella Passacquale United Kingdom 15 108 0.8× 124 0.9× 152 1.2× 93 0.8× 68 0.8× 22 743
Li Wen China 20 104 0.8× 114 0.8× 198 1.6× 84 0.8× 89 1.1× 73 871
Rebecca Halbgebauer Germany 13 101 0.7× 197 1.4× 188 1.5× 129 1.2× 54 0.7× 34 640
György Acsády Hungary 12 107 0.8× 72 0.5× 106 0.9× 55 0.5× 55 0.7× 35 450
Eirini Kitsiouli Greece 14 59 0.4× 104 0.8× 133 1.1× 128 1.1× 52 0.7× 20 669
Claudia Bănescu Romania 19 209 1.5× 118 0.9× 347 2.8× 139 1.2× 115 1.4× 113 1.1k

Countries citing papers authored by Rafi Mazor

Since Specialization
Citations

This map shows the geographic impact of Rafi Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafi Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafi Mazor more than expected).

Fields of papers citing papers by Rafi Mazor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafi Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafi Mazor. The network helps show where Rafi Mazor may publish in the future.

Co-authorship network of co-authors of Rafi Mazor

This figure shows the co-authorship network connecting the top 25 collaborators of Rafi Mazor. A scholar is included among the top collaborators of Rafi Mazor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafi Mazor. Rafi Mazor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santos, Fernando dos, Rafi Mazor, Laura Beretta, et al.. (2023). Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis. Frontiers in Molecular Biosciences. 9. 1051471–1051471. 4 indexed citations
2.
Santos, Fernando dos, et al.. (2022). Efficacy of Tranexamic Acid in Blood Versus Crystalloid-Resuscitated Trauma/Hemorrhagic Shock. Journal of Surgical Research. 279. 89–96.
3.
Mazor, Rafi, Peter J. Littrup, Michael Sturek, et al.. (2022). Mesenteric fat cryolipolysis attenuates insulin resistance in the Ossabaw swine model of the metabolic syndrome. Surgery for Obesity and Related Diseases. 19(4). 374–383. 4 indexed citations
4.
Santos, Fernando dos, et al.. (2022). Enteral gabexate mesilate improves volume requirements and autonomic cardiovascular function after experimental trauma/hemorrhagic shock in the absence of blood reperfusion.. PubMed. 14(10). 7391–7402. 2 indexed citations
5.
Mazor, Rafi, et al.. (2021). Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock. Critical Care Explorations. 3(7). e0469–e0469. 2 indexed citations
7.
Aletti, Federico, et al.. (2019). Enteral Tranexamic Acid Decreases Proteolytic Activity in the Heart in Acute Experimental Hemorrhagic Shock. Journal of Cardiovascular Pharmacology and Therapeutics. 24(5). 484–493. 2 indexed citations
8.
Mazor, Rafi, Dinorah Friedmann‐Morvinski, Tom Alsaigh, et al.. (2018). Cleavage of the leptin receptor by matrix metalloproteinase–2 promotes leptin resistance and obesity in mice. Science Translational Medicine. 10(455). 54 indexed citations
9.
Mazor, Rafi, et al.. (2016). Pancreatic Trypsin and Insulin Receptor Cleavage in High Fat Diet Rats. The FASEB Journal. 30(S1). 1 indexed citations
10.
Mazor, Rafi & Geert W. Schmid‐Schönbein. (2016). Proteolytic receptor cleavage in the pathogenesis of blood rheology and co-morbidities in metabolic syndrome. Early forms of autodigestion. Biorheology. 52(5-6). 337–352. 11 indexed citations
11.
Alsaigh, Tom, et al.. (2014). Cellular and molecular basis of Venous insufficiency. PubMed. 6(1). 24–24. 68 indexed citations
12.
Cohen-Mazor, Meital, Rafi Mazor, Batya Kristal, & Shifra Sela. (2014). Elastase and Cathepsin G from Primed Leukocytes Cleave Vascular Endothelial Cadherin in Hemodialysis Patients. BioMed Research International. 2014. 1–10. 26 indexed citations
13.
Mazor, Rafi, Tom Alsaigh, Helena Shaked, et al.. (2012). Matrix Metalloproteinase-1-mediated Up-regulation of Vascular Endothelial Growth Factor-2 in Endothelial Cells. Journal of Biological Chemistry. 288(1). 598–607. 66 indexed citations
14.
Mazor, Rafi, Batya Kristal, Meital Cohen-Mazor, et al.. (2007). The polymorphonuclear leukocyte contributes to the development of hypertension in the Sabra rat. Journal of Hypertension. 25(11). 2249–2256. 5 indexed citations
15.
Mazor, Rafi, Revital Shurtz-Swirski, Raymond Farah, et al.. (2007). Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Atherosclerosis. 197(2). 937–943. 81 indexed citations
16.
Cohen-Mazor, Meital, Shifra Sela, Rafi Mazor, et al.. (2007). Are primed polymorphonuclear leukocytes contributors to the high heparanase levels in hemodialysis patients?. American Journal of Physiology-Heart and Circulatory Physiology. 294(2). H651–H658. 18 indexed citations
17.
Mazor, Rafi, Revital Shurtz-Swirski, Shifra Sela, Galina Shapiro, & Batya Kristal. (2006). [Polymorphonuclear leukocyte priming and counts are in correlation with blood pressure parameters].. PubMed. 145(12). 900–3, 941. 2 indexed citations
18.
Sela, Shifra, Revital Shurtz-Swirski, Meital Cohen-Mazor, et al.. (2005). Primed Peripheral Polymorphonuclear Leukocyte. Journal of the American Society of Nephrology. 16(8). 2431–2438. 162 indexed citations
19.
Mazor, Rafi, et al.. (2005). A key role for primed polymorphonuclear leukocyte NADPH oxidase in the development of hypertension. American Journal of Hypertension. 18(5). A184–A184. 1 indexed citations
20.
Sela, Shifra, et al.. (2004). Primed Polymorphonuclear Leukocytes, Oxidative Stress, and Inflammation Antecede Hypertension in the Sabra Rat. Hypertension. 44(5). 764–769. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026